(Q50891287)

24 March 2018

title

Somatic mutations in histiocytic sarcoma identified by next generation sequencing. (English)

1 reference

24 March 2018

1 reference

4

1 reference

24 March 2018

author name string

Qingqing Liu

1

1 reference

24 March 2018

Keith Tomaszewicz

2

1 reference

24 March 2018

Lloyd Hutchinson

3

1 reference

24 March 2018

Bruce Woda

5

1 reference

24 March 2018

Hongbo Yu

6

1 reference

24 March 2018

publication date

3 June 2016

1 reference

24 March 2018

published in

Virchows Archiv

1 reference

24 March 2018

volume

469

1 reference

24 March 2018

page(s)

233-241

1 reference

24 March 2018

issue

2

1 reference

24 March 2018

describes a project that uses

massive parallel sequencing

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-016-1965-2

inferred from title

exact match

0 references

cites work

Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

BRAFV600EMutation in a Histiocytic Sarcoma Arising From Hairy Cell Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

The VEGF signaling pathway in cancer: the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Recurrent BRAF mutations in Langerhans cell histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

dbSNP: the NCBI database of genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

BRAF targeted therapy changes the treatment paradigm in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1965-2

Malignant Histiocytic Neoplasms of the Small Intestine

21 January 2018

1 reference

12 December 2020

Polymorphisms of KDR gene are associated with coronary heart disease

1 reference

12 December 2020

Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab

1 reference

12 December 2020

Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy

1 reference

12 December 2020

True histiocytic lymphoma with multiple skin nodules

1 reference

12 December 2020

10.1007/S00428-016-1965-2

Identifiers

DOI

1 reference

24 March 2018

PubMed ID

27259537

1 reference

24 March 2018